AutoimmuneInflammatory Arthritis Associated Lymphomas: Who Is at Risk?

Abstract EN

Specific autoimmune and inflammatory rheumatic diseases have been associated with an increased risk of malignant lymphomas.

Conditions such as rheumatoid arthritis (RA), primary Sjögren’s syndrome (pSS), systemic lupus erythematosus (SLE), dermatomyositis, and celiac disease have been consistently linked to malignant lymphomas.

Isolated cases of lymphomas associated with spondyloarthropathies and autoinflammatory diseases have also been reported.

Direct association between autoimmunity and lymphomagenesis has been reinforced by large epidemiological studies.

It is still uncertain whether disease specific determinants or phenotypic or treatment related characteristics increase likelihood of lymphomagenesis in these patients.

For example, recent literature has indicated a positive correlation between severity of inflammation and risk of lymphomas among RA and Sjögren’s syndrome patients.

It is also debated whether specific lymphoma variants are more commonly seen in accordance with certain chronic autoimmune arthritis.

Previous studies have revealed a higher incidence of diffuse large B-cell lymphomas in RA and SLE patients, whereas pSS has been linked with increased risk of mucosa-associated lymphoid tissue lymphoma.

This review summarizes recent literature evaluating risk of lymphomas in arthritis patients and disease specific risk determinants.

We also elaborate on the association of autoimmune arthritis with specific lymphoma variants along with genetic, environmental, and therapeutic risk factors.